期刊文献+

芪苈强心胶囊辅治高龄慢性心力衰竭患者30例临床观察 被引量:2

The therapeutic effect of Qiliqiangxin capsule on chronic heart failure in very elderly patients
下载PDF
导出
摘要 目的评价芪苈强心胶囊治疗高龄慢性心力衰竭患者的临床疗效及安全性,为临床合理用药提供依据。方法入选≥80岁老年慢性心力衰竭患者60例,随机分为对照组和治疗组,每组30例。2组均给予利尿剂、琥珀酸美托洛尔缓释片(倍他乐克)或地高辛等常规西药治疗.治疗组另加服芪苈强心胶囊4粒,每天3次。治疗8周后对比观察临床疗效、血清脑钠肽(BNP)和心脏彩色Doppler超声心动图检测心功能指标(CI、LVEF、SV、CO),并观察不良反应。结果疗程结束后治疗组临床总有效率为93.33%(28/30),高于对照组73.34%(22/30),差异有统计学意义(P<0.05)。BNP水平2组治疗后均较治疗前降低(P<0.05),治疗组较对照组BNP水平下降更明显(P<0.05)。HR、SV、CO、CI、LVEF值2组治疗后较治疗前有所改善(P<0.05),但2组间比较差异无统计学意义(P>0.05)。2组均未发生严重不良反应。结论芪苈强心胶囊辅治慢性心力衰竭疗效明确,安全性好,可作为高龄慢性心力衰竭患者的药物治疗选择之一。 Objective To evaluate the clinical efficacy of Qiliqiangxin capsule and safety on very elderly patients with chronic heart failure , and provide the basis for rational drug use .Methods 60 patients who were ≥80 year old with chronic heart failure were enrolled and randomly divided into control group and the treatment group , 30 cases in each group .2 groups were given diuretics , metoprolol succinate extended release tablets ( metoprolol ) or digoxin and other conventional western medicine, treatment group plus Qiliqiangxin capsule, 3 times a day.After 8 weeks of treatment, observed the clinical efficacy of serum brain natriuretic peptide ( BNP) and cardiac color Doppler echocardiography cardiac function index ( CI, LVEF, SV, CO) , and observed adverse reactions .Results In treatment group after treatment , the total effective rate was 93.33%(28/30), higher than control group of 73.34%(22/30), the difference was statistically significant ( P 〈0.05). BNP levels in the two groups after treatment were reduced than before treatment ( P 〈0.05), the treatment group compared with the control group, BNP levels decreased more significantly ( P 〈0.05).After treatment, HR, SV, CO, CI, LVEF val-ues of the two groups were improved than before treatment ( P 〈0.05), but no difference between the two groups was statisti-cally significant ( P &gt;0.05).Both two groups found no serious adverse events .Conclusion Qiliqiangxin capsule clearly assisted treatment of chronic heart failure efficacy , safety, and can be used in very elderly patients with chronic heart failure .
出处 《疑难病杂志》 CAS 2014年第4期339-341,共3页 Chinese Journal of Difficult and Complicated Cases
关键词 芪苈强心胶囊 高龄老年 心力衰竭 慢性 临床研究 Qiliqiangxin capsule Very elderly Heart failure,chronic Clinical research
  • 相关文献

参考文献12

  • 1黄岚,王江.心力衰竭发病机制的研究现状[J].中华临床医师杂志(电子版),2013,7(11):7-9. 被引量:34
  • 2Dickstein K , Cohen-Solal A, Filippatos G,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 : the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in col- laboration with the Heart Failure Association of the ESC (HFA)and en- dorsed by the European Society of Intensive Care Medicine (ES1CM). [ J ]. Eur Heart J,2008, 29 ( 19 ) :2388-2442. 被引量:1
  • 3陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2009:274. 被引量:260
  • 4周淑新,朱翠明,King M,Kingery JE,Casey B.心力衰竭的诊断与评估[J].中国全科医学,2012,15(36):4153-4157. 被引量:38
  • 5李为民,张晓伟.2012年欧洲心脏病学会急慢性心力衰竭指南解读[J].中国循环杂志,2012,27(11):33-34. 被引量:2
  • 6McMurray JJ,Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in col- laboration with the Heart Failure Association (HFA)of the ESC [ J]. Eur Heart J ,2012,33(14) :1787-1847. 被引量:1
  • 7Takano H, Hasegawa H, Nagai T, et al. Implication of cardiac remode- ling in heart failure : mechanisms and therapeutic strategies [ J ]. Intern Med, 2003,42 ( 6 ) : 465-469. 被引量:1
  • 8Javier D. Altered degradation of extracellular matrix in myocardial re- modelling : the growing role of cathepsins and cystatins [ J ]. Cardiovase Res,2010,87(4) :591-592. 被引量:1
  • 9Kalogeropoulos AP, Georgiopoulou VV, Butler J. From risk factors to structural heart diaease:the role of inflammation [ J ]. Heart Fail Clin, 2012,8( 1 ) :113-123. 被引量:1
  • 10董晓蕾,常文静,蔡辉.炎性细胞因子与慢性心力衰竭[J].中华老年心脑血管病杂志,2013,15(4):438-441. 被引量:55

二级参考文献54

  • 1中华人民共和国卫生部.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002.115-119. 被引量:985
  • 2陈灏珠,主译.临床心脏病学[M].北京:科学技术出版社,1996:233. 被引量:9
  • 3Kalogeropoulos AP, Georgiopoulou VV,Butler J. From riskfactors to structural heart disease : the role of inflammation.Heart Fail Clin,20l2 ,8 : 113-123. 被引量:1
  • 4Tziakas D,Chalikias G’Parissis JT,et al. Prolonged activationof tumor necrosis factor(TNF")-alpha and its soluble receptorsin chronic heart failure patients both in the compensated anddecompensated state. Interplay between their levels and met-alloproteinase-3. Eur Cytokine Netw,2004 ,15 : 231-239. 被引量:1
  • 5Takayoshi T, Atsuyuki W, Matsumoto T, et al. Relationshipbetween tumor necrosis factor-alpha production and oxidativestress in the failing hearts of patients with dilated cardiomy-opathy. J Am Cardiol,2001,37 -.2086-2092. 被引量:1
  • 6Fernandez-Velasco M,Ruiz- Hurtado G, Hurtado O,et al.TNF-alpha downregulates transient outward potassium cur-rent in rat ventricular myocytes through iNOS overexpressionand oxidant species generation. Am J Physiol Heart CircPhysiol,2007.293:H238-H245. 被引量:1
  • 7Hamid T,Gu Y, Ortines RV. et al. Divergent tumor necrosisfactor receptor-related remodeling responses in heart failure:role of nuclear factor-kappaB and inflammatory activation.Circulation, 2009,119:1386-1397. 被引量:1
  • 8Niessner A,Hohensinner PJ,Rychli K,et al. Prognostic valueof apoptosis markers in advanced heart failure patients. EurHeart J,2009,30:789-796. 被引量:1
  • 9Seko Y.Ishiyama S,Nishikawa T,et al. Expression of tumornecrosis factor ligand superfamily costimulatory moleculesCD27L, CD30L, OX40L and 4-1BBL in the heart of patientswith acute myocarditis and dilated cardiomyopathy. Cardio-vasc Pathol, 2002.11 : 166-170. 被引量:1
  • 10Ueland T, Aukrust P, Yndestad A’et al. Soluble CD40 ligandin acute and chronic heart failure. Eur Heart J ,2005,26 s 1101-1107. 被引量:1

共引文献425

同被引文献31

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部